Cancer clot study tracks patient experience and costs

NCT ID NCT03407469

First seen Nov 18, 2025 · Last updated Jun 13, 2026 · Updated 24 times

Summary

This study follows 260 cancer patients who are on long-term blood-thinner medication for blood clots (VTE). Researchers will track how well patients take their medicine, their quality of life, and healthcare costs. The goal is to learn about patient experiences, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER-RELATED VENOUS THROMBOEMBOLISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fundacion Valle del Lili

    RECRUITING

    Cali, Colombia

    Contact Email: •••••@•••••

    Contact

  • Hospital Clinic

    RECRUITING

    Barcelona, Carrer de Villarroel, 170, 08036, Spain

    Contact

  • Hospital German Trias i Pujol

    RECRUITING

    Barcelona, 08916, Spain

    Contact Email: •••••@•••••

    Contact

  • University of Texas MD Anderson Cancer Center

    RECRUITING

    Houston, Texas, 77030, United States

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.